What is the cause of Jakob-Creutzfeldt disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cause of Creutzfeldt-Jakob Disease

Creutzfeldt-Jakob disease (CJD) is caused by misfolded prion proteins (PrPSc) that accumulate in the brain, leading to fatal neurodegeneration with characteristic spongiform changes in brain tissue. 1, 2

Pathophysiology of CJD

  • The disease results from the abnormal misfolding of normal prion protein (PrPc) into pathological conformers called prions (PrPSc) that act as templates for further protein misfolding 2
  • These misfolded prions accumulate in the brain, causing neuronal death and the characteristic spongiform changes seen in brain tissue 2
  • The misfolded prion proteins are resistant to normal protein degradation mechanisms, allowing them to progressively accumulate 1
  • The process leads to rapidly progressive neurodegeneration, resulting in fatal outcomes typically within months of symptom onset 1, 3

Types of CJD Based on Etiology

Sporadic CJD (sCJD)

  • Most common form, accounting for approximately 90% of all CJD cases 1
  • Occurs with an incidence of 1.5-2.0 cases per million person-years 1
  • Associated with spontaneous misfolding of prion protein without any known triggering factor 1
  • Different phenotypes are associated with Methionine/Valine (M/V) polymorphism at Codon 129 of the prion gene (PRNP) and with molecular mass of PrPSc (glycotype 1 and 2) 1

Genetic/Familial CJD

  • Caused by autosomal dominant protein-altering variants in the PRNP gene located on chromosome 20p13 2
  • Common pathogenic variants include E200K, P102L, D178N, and various octapeptide repeat insertions 2
  • Other genetic prion diseases include Gerstmann-Sträussler-Scheinker syndrome (GSS) and fatal familial insomnia (FFI) 2

Acquired CJD

  • Iatrogenic transmission through contaminated surgical instruments, cadaveric brain-derived products, and infected donor tissues (including dura mater and corneas) 4
  • Variant CJD (vCJD) linked to consumption of bovine spongiform encephalopathy (BSE) contaminated beef products 5
  • Transmission occurs through direct contact with infectious prion-containing tissue 4

Diagnostic Confirmation

  • Real-time Quaking Induced Conversion (RT-QuIC) assay of CSF has revolutionized diagnosis with excellent sensitivity and specificity 1, 3
  • Brain MRI with diffusion-weighted imaging (DWI) and fluid-attenuated inversion recovery (FLAIR) sequences shows characteristic changes in gray matter structures 3
  • CSF analysis for 14-3-3 protein and total Tau serves as supportive biomarkers 1, 3
  • EEG may show characteristic periodic sharp wave complexes in later stages 3

Clinical Implications

  • CJD is invariably fatal, with sporadic CJD having a median survival of approximately 5 months from symptom onset 3, 2
  • Early symptoms can be non-specific and variable, making diagnosis challenging 6
  • Common presentations include rapidly progressive dementia, cerebellar ataxia, myoclonus, and visual disturbances 1, 2
  • Atypical presentations may include isolated visual symptoms, aphasia, or seizures, which can delay diagnosis 6

Important Considerations

  • Stringent infection control measures are necessary when handling tissues or fluids from patients with suspected or confirmed CJD 4
  • Brain, ocular, and central nervous system tissues are highly infectious and require special containment or incineration 4
  • Genetic counseling should be offered to all families with a case of prion disease, regardless of apparent family history 2
  • Currently, there are no effective disease-modifying treatments for CJD 1, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Prion Disease Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management and Treatment for Creutzfeldt-Jakob Disease (CJD)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Creutzfeld-Jakob disease: recommendations for infection control.

American journal of infection control, 1994

Research

From Creutzfeldt-Jakob disease to the mad cow epidemic.

The Journal of emergency medicine, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.